2024. Deucravacitinib in Moderate Plaque Psoriasis: Efficacy in the Phase 3 POETYK PSO-1 and PSO-2 Trials . SKIN The Journal of Cutaneous Medicine. 8, 2 (Mar. 2024), s364. DOI:https://doi.org/10.25251/skin.8.supp.364.